Dose Escalation Study of Vinpocetine in Healthy Volunteers
ConditionFetal Alcohol Spectrum Disorders
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-40
SponsorStanford University
About this trial
The objective of this study is to determine whether vinpocetine is safe when taken at higher doses.
Eligibility criteria
Qualifiers
Healthy adults 18-40 years old.
Proficient English.
Use of appropriate contraception if woman of childbearing potential.
Disqualifiers
Major medical disease (e.g., epilepsy, diabetes, heart disease, active cancer, depression).
Those who score >18 overall on the BDI-II or >0 for item #9 (suicidal thoughts) at screening.
Use of centrally active medications.
History of allergy to vinpocetine.
Trial design
Treatments tested in this trial
- Vinpocetine
Treatment groups
20 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Stanford University
Lead sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator
Source ClinicalTrials.gov